Improvement of dissolution rate of tacrolimus by solid dispersion technique

Journal of Pharmaceutical Investigation

Volumn 43, Issue 1, 2013, Pages 45-53

  Patel, Pranav V ^b   Panchal, Shital S ^a   Mehta, Tejal A ^a  

^a NIRMA UNIVERSITY   (India)

^b KB Raval College of Pharmacy   (India)

Author keywords

Adsorbent; Gelucire 44 14 ; Gelucire 50 15 ; Solid dispersion (SD); Tacrolimus

Indexed keywords

GELUCIRE; LACTOSE; TACROLIMUS;

ARTICLE; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DRUG RELEASE; DRUG SOLUBILITY; DRUG STABILITY; DRUG STORAGE; IN VITRO STUDY; INFRARED SPECTROSCOPY; KINETICS; MATHEMATICAL MODEL; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; X RAY DIFFRACTION;

EID: 84874799989     PISSN: 20935552     EISSN: 20936214     Source Type: Journal    
DOI: 10.1007/s40005-013-0053-8     Document Type: Article

References (22)

1. Ahuja N, Katare OP, Singh B (2007) Studies on dissolution enhancement and mathematical modeling of drug release of a poorly water-soluble drug using water-soluble carriers. Eur J Pharm Biopharm 65: 26-38.
2. Babu GV, Prasad CD, Murthy KV (2002) Evaluation of modified gum karaya as carrier for the dissolution enhancement of poorly water soluble drug nimodipine. Int J Pharm 234: 1-17.
3. Baykara T, Yuksel N (1991) The preparation of prolonged action formulations in the form of semi solid matrix into hard gelatine capsules. I Thermocap method. Drug Dev Ind Pharm 17: 1215-1227.
4. Bhattacharyya M, Basu SK, Gupta BK, Ghosal SK, Mandal SC, Chattaraj SC (1993) Formulation and in vitro-in vivo characterization of solid dispersions of piroxicam. Drug Dev Ind Pharm 19: 29-35.
5. Crison JR, Lipka E, Kim JS, Amidon GL (1997) Lipid-filled hard gelatine capsules as novel drug delivery systems with application to nifedipine. Bull Tech Gattefosse 90: 71-73.
6. Damian F, Blaton N, Kinget R, van den Mooter G (2002) Physical stability of solid dispersions of the antiviral agent UC-781 with PEG 6000, Gelucire† 44/14 and PVP K30. Int J Pharm 244: 87-98.
7. Deepti DH, Madan AK (2007) Solid dispersion adsorbates for enhancement of dissolution rates of drugs. PDA J Pharm Sci Technol 61: 97-101.
8. Duijnhoven EV, Christiaans M, Undre N, Stevenson P, Hooff JV (1998) The effect of breakfast on the oral bioavailability of tacrolimus in diabetic and nondiabetic patients before transplantation. Transplant Proc 30: 1268-1270.
9. European Pharmacopoeia (2002), 4th edn. Council of Europe, Strasbourg, France p 804, 1449.
10. Gattefosse Product Literature, Gattefosse (1999) Pharmaceutical excipient for oral semi-solid formulations, Gelucire 44/14-Prompt release and enhanced bioavailability, PF 96327, 1st edn.
11. Gershanik T, Benita S (2000) Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs. Eur J Pharm Biopharm 50: 179-188.
12. Hane K, Fujioka M, Namiki Y, Kitagawa T, Kihara N, Shimatani K, Yasuda T (1992) Physico-chemical properties of (-)-1R, 9S, 12S, 13R, 14S, 17R, 18E, 21S, 23S, 24R, 25S, 27R)-17- allyl-1, 14-dihydroxy-12-[(E)-2-[(1R, 3R, 4R)-4-hydroxy-3-methoxycyclohexyl]- 1-methylvinyl]-23, 25-dimethoxy-13, 19, 21, 27-tetrametyl-11, 28-dioxa-4-azatricyclo[22. 3. 1. 04, 9]octacos- 18-ene-2, 3, 10, 16-tetrone hydrate (FK-506). Iyakuhin Kenkyu 23: 33-43.
13. Higuchi T, Connors KA (1965) Phase-solubility techniques. Adv Anal Chem Instrum 4: 117-210.
14. Kazunari Y, Toshiomi N, Kazuto O, Atsuo O, Yuji T, Rinta I, Kazutaka H, Toshikiro K (2003) Establishment of new preparation method for solid dispersion formulation of tacrolimus. Int J Pharm 267: 79-91.
15. Kershner RP, Fitzsimmons WE (1996) Relationship of FK506 whole blood concentrations and efficacy and toxicity after liver and kidney transplantation. Transplantation 62: 920-926.
16. Kimura E, Bersani-Amado CA, Sudo LS, Santos SR, Oga S (1997) Pharmacokinetic profile of piroxicam b-cyclodextrin in rat plasma and lymph. Gen Pharmacol 28: 695-698.
17. Paulo C (2001) Modeling and comparison of dissolution profiles. Eur J Pharm Sci 13: 123-133.
18. Ra′cz I (1989) Physicochemical interactions encountered in the course of drug product preparation. In: Drug Formulation. Wiley, New York, p 212-242.
19. Spencer CM, Goa KL, Gillis JC (1997) Tacrolimus: an update of its pharmacology and clinical efficacy in the management of organ transplantation. Drugs 54: 925-975.
20. Tantishaiyakul V, Kaewnopparat N, Ingkatawornwong S (1999) Properties of solid dispersions of piroxicam in polyvinylpyrrolidone. Int J Pharm 181: 143-151.
21. Venkataramanan R, Swaminathan A, Prasad T, Jain A, Zuckerman S, Warty V, McMichael J, Lever J, Burckart G, Starzl T (1995) Clinical pharmacokinetics of tacrolimus. Clin Pharmacokinet 29: 30-404.
22. Yoshioka M, Hancock BC, Zografi G (1995) Inhibition of indomethacin crystallization in poly(vinylpyrrolidone) coprecipitates. J Pharm Sci 84: 983-986.